Table 3.
Immobilization strategy | LOD (fgmL−1) | Dynamic Range | Sensitivity (nA/log (pg mL−1) | No. of Ab/Electrode (×109) | Percent active antibodies | Signal loss after 5 days storage |
---|---|---|---|---|---|---|
Anti-HRP/AuNP | 40 | 40 fg ML−1 | 2.40 | 6.2 ± 0.3 | 21% | ≤ 30% |
Anti-HRP/rGO | 40 | 40 fg mL−1 | 0.55 | 4.3 ± 0.3 | 30% | ≤ 35% |
Anti-HRP/Chitosan | 40 | 40 fg mL−1 | 0.90 | 6.1 ± 0.6 | 21% | ≤ 7% |
Anti-HRP/Protein A/AuNP | 40 | 40 fg mL−1 | 2.01 | 6.1 ± 0.4 | 85% | ≤ 20 |
Anti-HRP/bare electrode | 4 | 8 fg raL−1 | 1.75 | 1.1 ± 0.03 | 60% | >60% |
Anti-HRP/Protein A/bare electrode | 8 | 8 fg mL−1 | 1.62 | 0.26 ± 0.1 | 98% | ≤ 25 |